-
1
-
-
0035034752
-
Opsoclonus-Myoclonus-Ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies - A report from the Children's Cancer group study
-
Rudnick E, Khakoo Y, Antunes NL, et al. Opsoclonus-Myoclonus-Ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies - A report from the Children's Cancer group study. Med Pediatr Oncol 2001;36:612-622.
-
(2001)
Med Pediatr Oncol
, vol.36
, pp. 612-622
-
-
Rudnick, E.1
Khakoo, Y.2
Antunes, N.L.3
-
2
-
-
0026628656
-
The neurobiology of the opsoclonus-myoclonus syndrome
-
Pranzatelli MR. The neurobiology of the opsoclonus-myoclonus syndrome. Clin Neuropharmacol 1992;15:186-228.
-
(1992)
Clin Neuropharmacol
, vol.15
, pp. 186-228
-
-
Pranzatelli, M.R.1
-
3
-
-
0029655174
-
Case records of the Massachusetts General Hospital Weekly clinicopathological exercises
-
Scully RE, Mark EJ, MC Neely BU. Case records of the Massachusetts General Hospital Weekly clinicopathological exercises. N Eng J Med 1995;333:579-586.
-
(1995)
N Eng J Med
, vol.333
, pp. 579-586
-
-
Scully, R.E.1
Mark, E.J.2
Mc Neely, B.U.3
-
4
-
-
0030060753
-
The immunopharmacology of the opsoclonusmyoclonus syndrome
-
Pranzatelli MR. The immunopharmacology of the opsoclonusmyoclonus syndrome. Clin Neuropharmacol 1996;19:1-47.
-
(1996)
Clin Neuropharmacol
, vol.19
, pp. 1-47
-
-
Pranzatelli, M.R.1
-
5
-
-
0028339183
-
Anti-Hu antibody in a neuroblastoma associated paraneoplastic syndrome
-
Fisher PG, Wechsler DS, Singer HS. Anti-Hu antibody in a neuroblastoma associated paraneoplastic syndrome. Pediatr Neurol 1994;10:309-312.
-
(1994)
Pediatr Neurol
, vol.10
, pp. 309-312
-
-
Fisher, P.G.1
Wechsler, D.S.2
Singer, H.S.3
-
6
-
-
0029867260
-
Opsoclonus/myoclonus: Paraneoplastic syndrome of neuroblastoma
-
Janss A, Sladky J, Chatten J, et al. Opsoclonus/myoclonus: Paraneoplastic syndrome of neuroblastoma. Med Pediatr Oncol 1996;26:272-279.
-
(1996)
Med Pediatr Oncol
, vol.26
, pp. 272-279
-
-
Janss, A.1
Sladky, J.2
Chatten, J.3
-
7
-
-
0030973979
-
Long-term neurologic outcome in children with Opsoclonus-myoclonus associated with neuroblastoma: A report from the pediatric oncology group
-
Russo C, Cohn SL, Petruzzi MJ, et al. Long-term neurologic outcome in children with Opsoclonus-myoclonus associated with neuroblastoma: A report from the pediatric oncology group. Med Pediatr Oncol 1997;29:284-288.
-
(1997)
Med Pediatr Oncol
, vol.29
, pp. 284-288
-
-
Russo, C.1
Cohn, S.L.2
Petruzzi, M.J.3
-
8
-
-
0028005406
-
Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma
-
Koh PS, Raffensperger JG, Berry S. et al. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. J Pediatr 1994;125:712-716.
-
(1994)
J Pediatr
, vol.125
, pp. 712-716
-
-
Koh, P.S.1
Raffensperger, J.G.2
Berry, S.3
-
9
-
-
0030664467
-
Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma
-
Veneselli E, Conte M, Biancheri R, et al. Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma. Med Pediatr Oncol 1998;30:15-17.
-
(1998)
Med Pediatr Oncol
, vol.30
, pp. 15-17
-
-
Veneselli, E.1
Conte, M.2
Biancheri, R.3
-
10
-
-
0029164756
-
Neuroblastoma-associated opsoclonusmyoclonus treated with intravenously administered immune globulin G
-
Petruzzi MJ, Alarcon PA. Neuroblastoma-associated opsoclonusmyoclonus treated with intravenously administered immune globulin G. J Pediatr 1995;127:328-329.
-
(1995)
J Pediatr
, vol.127
, pp. 328-329
-
-
Petruzzi, M.J.1
Alarcon, P.A.2
-
11
-
-
0025604662
-
High-dose intravenous methylprednisolone (HIVMP) in hematological disorders
-
Özsoylu Ş. High-dose intravenous methylprednisolone (HIVMP) in hematological disorders. Hematol Rev 1990;4:197-207.
-
(1990)
Hematol Rev
, vol.4
, pp. 197-207
-
-
Özsoylu, Ş.1
|